FGFR-TKI possibly promotes MHC expression in tumor cells, which also affects T-cell activation [59], and also modulates TAMs programming, reduces MDSCs mobilization, and inhibits Treg cell generation, which can further prevent the immune escape of tumors [113, 114]. This evidence concerns the gene HLA-C and neoplasm.